Population-based incidence and mortality of community-acquired pneumonia in Germany

Autor: J. Schiffner-Rohe, Christof von Eiff, Ralf Sprenger, Friedhelm Leverkus, Dennis Häckl, Christian Theilacker, Jochen Walker
Jazyk: angličtina
Rok vydání: 2021
Předmět:
Male
European People
Pediatrics
Pulmonology
Epidemiology
German People
Geographical locations
Elderly
0302 clinical medicine
Community-acquired pneumonia
Germany
Outpatients
Medicine and Health Sciences
Ethnicities
Electronic Health Records
030212 general & internal medicine
Multidisciplinary
Cancer Risk Factors
Incidence
Incidence (epidemiology)
Mortality rate
Age Factors
Middle Aged
Europe
Community-Acquired Infections
Oncology
Medicine
Female
Research Article
Adult
medicine.medical_specialty
Patients
Adolescent
Death Rates
Science
Population based
Young Adult
03 medical and health sciences
Population Metrics
medicine
Adults
Humans
European Union
Mortality
Disease burden
Aged
Retrospective Studies
Population Biology
business.industry
Biology and Life Sciences
Retrospective cohort study
Pneumonia
medicine.disease
Health Care
030228 respiratory system
Age Groups
Medical Risk Factors
People and Places
Population Groupings
business
Zdroj: PLoS ONE, Vol 16, Iss 6, p e0253118 (2021)
PLoS ONE
ISSN: 1932-6203
Popis: Background Little information on the current burden of community-acquired pneumonia (CAP) in adults in Germany is available. Methods We conducted a retrospective cohort study using a representative healthcare claims database of approx. 4 million adults to estimate the incidence rates (IR) and associated mortality of CAP in 2015. IR and mortality were stratified by treatment setting, age group, and risk group status. A pneumonia coded in the primary diagnosis position or in the second diagnosis position with another pneumonia-related condition coded in the primary position was used as the base cases definition for the study. Sensitivity analyses using broader and more restrictive case definitions were also performed. Results The overall IR of CAP in adults ≥18 years was 1,054 cases per 100,000 person-years of observation. In adults aged 16 to 59 years, IR for overall CAP, hospitalized CAP and outpatient CAP was 551, 96 and 466 (with a hospitalization rate of 17%). In adults aged ≥60 years, the respective IR were 2,032, 1,061 and 1,053 (with a hospitalization rate of 52%). If any pneumonia coded in the primary or secondary diagnosis position was considered for hospitalized patients, the IR increased 1.5-fold to 1,560 in the elderly ≥60 years. The incidence of CAP hospitalizations was substantially higher in adults ≥18 years with at-risk conditions and high-risk conditions (IR of 608 and 1,552, respectively), compared to adults without underlying risk conditions (IR 108). High mortality of hospitalized CAP in adults ≥18 was observed in-hospital (18.5%), at 30 days (22.9%) and at one-year (44.5%) after CAP onset. Mortality was more than double in older adults in comparison to younger patients. Conclusion CAP burden in older adults and individuals with underlying risk conditions was high. Maximizing uptake of existing vaccines for respiratory diseases may help to mitigate the disease burden, especially in times of strained healthcare resources.
Databáze: OpenAIRE